References and Notes
<A NAME="RD18307ST-1A">1a</A>
Bossert F.
Meyer H.
Wehinger E.
Angew. Chem., Int. Ed. Engl.
1981,
20:
762
<A NAME="RD18307ST-1B">1b</A>
Nakayama H.
Kosoaka Y.
Heterocycles
1996,
42:
901
<A NAME="RD18307ST-1C">1c</A>
Godfraid T.
Miller R.
Wibo M.
Pharmacol. Rev.
1986,
38:
321
<A NAME="RD18307ST-1D">1d</A>
Mannhold R.
Jablonka B.
Voigdt W.
Schoenafinger K.
Schravan K.
Eur. J. Med. Chem.
1992,
229
<A NAME="RD18307ST-2A">2a</A>
Buhler FR.
Kiowski W.
J. Hypertens.
1987,
5:
S3
<A NAME="RD18307ST-2B">2b</A>
Reid GL.
Meredith PA.
Pasanisi F.
J. Cardiovasc. Pharmacol.
1985,
7:
S18
<A NAME="RD18307ST-3A">3a</A>
Sausins A.
Duburs G.
Heterocycles
1988,
27:
279
<A NAME="RD18307ST-3B">3b</A>
Mager PP.
Coburan RA.
Solo AJ.
Trigle DJ.
Rothe H.
Drug Des. Discovery
1992,
8:
273
<A NAME="RD18307ST-3C">3c</A>
Clusa V.
Drugs Future
1995,
20:
135
<A NAME="RD18307ST-3D">3d</A>
Boer R.
Gekeler V.
Drugs Future
1995,
20:
499
<A NAME="RD18307ST-4A">4a</A>
Ruppert R.
Jeandon C.
Sgambati A.
Callot HJ.
Chem. Commun.
1999,
2123
<A NAME="RD18307ST-4B">4b</A>
Menche D.
Hassfeld J.
Li J.
Menche G.
Ritter A.
Rudolph S.
Org. Lett.
2006,
8:
741
<A NAME="RD18307ST-4C">4c</A>
Garden SJ.
Guimarães CRW.
Corréa MB.
Oleveira CAFD.
Pinto ADC.
Alencastro RBD.
J. Org. Chem.
2003,
68:
8815
<A NAME="RD18307ST-4D">4d</A>
Quellet SG.
Tuttle JB.
MacMillan DWC.
J. Am. Chem. Soc.
2005,
127:
32
<A NAME="RD18307ST-4E">4e</A>
Martin NJA.
List B.
J. Am. Chem. Soc.
2006,
128:
13368
<A NAME="RD18307ST-5A">5a</A>
Love B.
Sander KM.
J. Org. Chem.
1965,
30:
1914
<A NAME="RD18307ST-5B">5b</A>
Hantzsch A.
Ber. Dtsch. Chem. Ges.
1888,
21:
942
<A NAME="RD18307ST-6A">6a</A>
Chari MA.
Syamasundar K.
Catal. Commun.
2005,
6:
624
<A NAME="RD18307ST-6B">6b</A>
Gordeev MF.
Patel DV.
Gordon EM.
J. Org. Chem.
1996,
61:
924
<A NAME="RD18307ST-6C">6c</A>
Yadav JS.
Reddy BVS.
Basak AK.
Narasaiah AV.
Green Chem.
2003,
5:
3
<A NAME="RD18307ST-6D">6d</A>
Maquestiau A.
Maeyence A.
Eynde JJV.
Tetrahedron Lett.
1991,
32:
3839
<A NAME="RD18307ST-6E">6e</A>
Ohberg L.
Westman J.
Synlett
2001,
1296
<A NAME="RD18307ST-6F">6f</A>
Anniyappan M.
Muralidharan D.
Perumal PT.
Synth. Commun.
2002,
32:
659
<A NAME="RD18307ST-7A">7a</A>
Ko S.
Yao C.-F.
Tetrahedron
2006,
62:
7293
<A NAME="RD18307ST-7B">7b</A>
Heravi MM.
Bakhtiari K.
Javadi NM.
Bamoharram FF.
Saeedi M.
Oskooie HA.
J. Mol. Catal. A.: Chem.
2007,
264:
50
<A NAME="RD18307ST-7C">7c</A>
Kumar A.
Maurya RA.
Tetrahedron
2007,
63:
1946
<A NAME="RD18307ST-7D">7d</A>
Wang L.-M.
Sheng J.
Zhang L.
Han J.-W.
Fan Z.-Y.
Tian H.
Qian C.-T.
Tetrahedron
2005,
61:
1539
<A NAME="RD18307ST-8">8</A>
Typical Experimental Procedure for the Synthesis of 1,4-Dihydropyridine Derivatives
In a 25 mL round-bottomed flask, benzaldehyde (1 mmol), ethyl acetoacetate (2 mmol),
NH4OAc (1 mmol), and PTSA (0.1 mmol) was added. To this an aqueous solution of SDS (3
mL, 0.1 M) was added. The reaction mixture was immersed in an ultrasonic bath and
irradiated for 1 h. Then, the reaction mixture was diluted with brine and extracted
with EtOAc. The organic layer was dried over anhyd Na2SO4 and concentrated to give a crude product. The pure product was obtained by crystallization
of the crude material from MeOH; mp 158 °C. 1H NMR (200 MHz, CDCl3): δ = 1.21 (t, J = 7.7 Hz, 6 H), 2.29 (s, 6 H), 4.08 (q, J = 7.7 Hz, 4 H), 4.98 (s, 1 H), 6.00 (s, 1 H), 7.01-7.26 (m, 5 H). IR (KBr): 3322,
1676, 1633 cm-1. MS: m/z = 330 [M + H]+. Anal. Calcd for C19H23NO4: C, 69.28, H, 7.04, N, 4.25. Found: C, 69.12, H, 6.98, N, 4.14.
<A NAME="RD18307ST-9">9</A>
Typical Experimental Procedure for the Synthesis of Polyhydroquinoline Derivatives
In a 25 mL round-bottomed flask, dimedone (1 mmol), benzaldehyde (1 mmol), ethyl acetoacetate
(1 mmol), NH4OAc (1 mmol), and PTSA (0.1 mmol) was added. To this an aqueous solution of SDS (3
mL, 0.1 M) was added. The reaction mixture was immersed in an ultrasonic bath and
irradiated until reaction was complete (TLC monitoring, 1-3 h). The reaction mixture
was diluted with brine and extracted with EtOAc. The organic layer was dried over
anhyd Na2SO4 and concentrated to give a crude product. The pure product was obtained by crystallization
from MeOH; mp 203-204 °C. 1H NMR (300 MHz, CDCl3): δ = 0.94 (s, 3 H), 1.07 (s, 3 H), 1.21 (t, J = 7.1 Hz, 3 H), 2.13-2.29 (m, 4 H), 2.35 (s, 3 H), 4.06 (q, J = 7.1 Hz, 2 H), 5.07 (s, 1 H), 6.64 (s, 1 H), 7.08-7.13 (m, 1 H), 7.18-7.23 (m, 2
H), 7.28-7.33 (m, 2 H). 13C NMR (75 MHz, CDCl3): δ = 12.92, 17.96, 25.84, 28.15, 31.38, 35.33, 39.65, 49.50, 58.52, 104.72, 110.70,
124.74, 126.59, 126.72, 142.41, 145.82, 147.47, 166.24, 194.43. IR (KBr): 3287, 3078,
2963, 1697, 1611
cm-1. MS: m/z = 340 [M + H]+. Anal. Calcd for C21H25NO3: C, 74.31, H, 7.42, N, 4.13. Found: C, 74.27, H, 7.39, N, 4.08.